Synthetic cathinone poisoning from ingestion of drug-laced “instant coffee packets” in Taiwan

Abstract

Background:

Synthetic cathinone abuse is a global health issue. Synthetic cathinones emerged in Taiwan in 2009, and their prevalence rapidly rose. They are usually made into “instant coffee packets,” and these so-called “toxic coffee packets” may also contain psychoactive drugs other than synthetic cathinones. Due to the diversity of the ingredients, clinical presentations can be complex.

Methods:

Retrospective analysis of emergency department (ED) patients who reported ingesting toxic coffee packets at three Chang-Gung Memorial Hospitals located in northern Taiwan between January, 2015 and December, 2019.

Results:

Sixty patients were included. Their mean age was 28.85 ± 9.24 years and 47(78.33%) were male. The most common presentations were palpitation, agitation, hallucination, and altered consciousness. Tachycardia and hypertension were common, while hyperthermia was observed in only three patients. Three patients (5%) developed rhabdomyolysis, and one underwent transient hemodialysis. Most patients were discharged from the ED, but 15(25%) were admitted, of whom nine (15%) were admitted to the intensive care unit (ICU), and one eventually died. Confirmation tests (mass-spectrometry-based analysis) were available in 10 patients; all reported positive for at least one type of synthetic cathinone. Polysubstance exposure was common. In multivariate logistic regression analyses, Glasgow coma scale ≤13 and the presence of seizure were associated with ICU admission.

Conclusion:

Patients who report ingesting toxic coffee packets are very likely to have been exposed to synthetic cathinones. Polysubstance exposure is common following ingestion. Cardiovascular and neurological symptoms are the main presentations, and severe complications such as rhabdomyolysis and life-threatening dysrhythmia can occur.

Keywords

Drug abuse emergency medicine new psychoactive substances stimulants synthetic cathinones

Introduction

New psychoactive substances (NPS), usually considered to be substances with stimulant properties that are not controlled by the Single Convention on Narcotic Drugs of 1961 or the Convention on Psychotropic Substances of 1971, have become a threat to public health in many countries.^1,2 NPS involve several classes of drugs, of which synthetic cathinones are a major type used for recreational purposes.^3,4 By mid-2019, the United Nations Office on Drugs and Crime (UNODC) listed a total of 964 substances on their NPS database, of which 169 were cathinone derivatives.⁵

Cathinone is a naturally occurring β-ketone analog of amphetamine found in the leaves of khat (Catha edulis), a plant indigenous to northeast Africa and the Arabian Peninsula.⁶ Synthetic cathinones are human-made cathinone derivatives that directly and indirectly activate the sympathetic nervous system resulting in pharmacological effects similar to those of amphetamine and 3,4-methylenedioxy-methamphetamine (MDMA). The first synthetic cathinone, methcathinone, was synthesized in 1928, followed by the synthesis of mephedrone in 1929.⁷ Methcathinone was initially used in the former Soviet Union as an antidepressant in the 1930s but was removed from the market due to its strong addictive potential.⁸ In 2007, reports of mephedrone use emerged, first in Israel and then in four other countries.⁷ In 2009 and 2010, the abuse of synthetic cathinones (especially mephedrone) became prevalent in Western Europe.⁹ Abuse of synthetic cathinones also appeared in the United States in 2010, mainly methylenedioxypyrovalerone (MDPV) and methylone, and increased rapidly over the next few years.⁶

In Western countries, synthetic cathinones are frequently sold as “bath salts” despite having no such purpose.⁶ They can also be made into other products, such as traditional tablets/pills, plant food/fertilizer, insect repellant, pond cleaner, and vacuum fresheners,¹⁰ and may be sold as different products in different countries.¹¹ They are usually insufflated or swallowed in powder or crystal form but can also be administered by smoking, mucosal delivery, or injection via intramuscular or other routes.¹²

Synthetic cathinones emerged in the Taiwan illicit drug market in 2009,¹³ and their prevalence rapidly rose.^14,15 They were made or mixed into various products,¹⁶ and among them, instant coffee packets (psychoactive substances mixed with instant coffee powder) were the most popular.^14,16,17 In Taiwan, illicit ketamine was the most popular NPS from the early 2000s until 2016. Since early 2010, an increasing number of drug-laced instant coffee packets have been seized. Synthetic cathinones have replaced ketamine as the most predominant NPS in the illicit drug market since 2017.¹⁴ These so-called “toxic coffee packets” include various packaging (Figure 1) and may contain psychoactive drugs other than synthetic cathinones.^18,19 Although these products have been popular in Taiwan for a few years, only small numbers of synthetic cathinone poisonings have been identified in the medical system.^15,18 Clinical studies regarding synthetic cathinone poisoning from instant coffee packets are also limited.

Figure 1.

“Toxic coffee packets” in various packaging. The photos were adapted with the approval of the National Police Agency, Minister of Interior, Republic of China (Taiwan). Retrieved June 26, 2020 from URL: https://www.cib.gov.tw/Drup/Detail/76.

Synthetic cathinones represent a broad class of pharmacologically active compounds that induce numerous effects with different mechanisms of action.²⁰ Additionally, due to the diversity of the ingredients of toxic coffee packets, the clinical presentation following ingestion can be complex and unpredictable. In this study, we aimed to evaluate the demographics and clinical features of patients who ingested toxic coffee packets and presented to an emergency department (ED).

Materials and methods

We retrospectively reviewed the medical charts of ED patients who reported ingesting toxic coffee packets at three Chang-Gung Memorial Hospitals located in northern Taiwan between January, 2015 and December, 2019. Exposure history could have been self-reported by the patient or provided by any of the relevant personnel including family members, friends, paramedics, or the police. The three hospitals were Linkou Chang-Gung Memorial Hospital (medical center; annual ED visits approximately 180,000), Taipei Chang-Gung Memorial Hospital (local hospital; annual ED visits approximately 5000), and Keelung Chang-Gung Memorial Hospital (regional hospital; annual ED visits approximately 6000). This study was approved by the Chang-Gung Medical Foundation Institutional Review Board (No. 202000882B0).

The exposure history, time of ingestion, age, sex, initial vital signs, initial Glasgow coma scale (GCS) score, clinical symptoms, laboratory data, urine drug screening results (by immunoassay), confirmation test results (qualitative mass-spectrometry-based analysis for commonly abused drugs in patients’ urine samples), hospital flow, severity of toxicity (recorded as Poison Severity Score),²¹ poisoning-related therapies, and outcomes were recorded for descriptive analysis. A comparative analysis was conducted between patients who were or were not admitted to the intensive care unit (ICU). We also performed a multivariate analysis to evaluate the factors associated with the ICU admission.

Statistical procedures

The Mann–Whitney U test was used to compare continuous variables between groups, and the chi-square or Fisher’s exact test was used to compare categorical variables between groups, as appropriate. A p-value <0.05 was considered statistically significant. Baseline characteristics highly associated with ICU admission (p < 0.1) were then fitted into both univariate and multivariate logistic regression analyses. The odds ratios (ORs) and relevant 95% confidence intervals (CIs) were calculated. All analyses were performed using SAS Enterprise Guide 9.4.

Results

In total, 60 patients who reported ingestion of “toxic coffee packets” were included in the analysis: 47 (78.33%) were male and 13 (21.67%) were female. The majority (43 patients, 71.7%) of patients reported ingesting instant coffee packets only, while the other 17 patients reported ingesting other drugs simultaneously (Table 1). Their mean age was 28.85 ± 9.24 years. In general, case numbers increased from 2015 through 2018 and decreased slightly in 2019 (Figure 2). The most common presentation was palpitation (41.7%), followed by agitation (31.7%), hallucinations (31.7%), and altered mental status (25%, defined as GCS score <15). Four patients (6.7%) had a seizure episode and six patients (10%) presented with a concomitant trauma. Tachycardia (63.3%) and hypertension (36.7%) were common, while hyperthermia with a body temperature (BT) >38°C was observed in only three patients (5%). Laboratory testing revealed creatine kinase (CK) elevation in 16 patients; three of these patients had CK levels above 10,000 U/L. All three patients developed acute kidney injury (AKI), and one underwent transient hemodialysis. Ten patients had an abnormal serum creatinine level in their admission laboratory data. Hyponatremia was found in five patients, of whom only one had significant hyponatremia, at 120 meq/L (Table 1).

Table 1.

Demographic and clinical data of patients. Data represent case numbers of the parameter and its percentage. Continuous data are presented as mean values ± SD; laboratory parameters are shown as number of positive results/number of tests done.

Total 60 patients	n (%)		n (%)
General data		Laboratory findings (n/total tests)
Age (years, mean ± SD)	28.85 ± 9.24	Leukocytosis	27/54
Male sex	47 (78.3)	Cr elevation	10/53
Intentional use	52 (86.7)	CK elevation	16/19
History of psychiatric disorder	5 (8.3)	CK > 10,000 U/L	3/19
Toxic coffee packet use only	43 (71.7)	Na < 135 mEq/L	5/52
		Blood pH < 7.25	4/46
Presentations		Bicarbonate <20 mEq/L	8/46
Palpitation	25 (41.7)	Urine amphetamine screen (+)	23/45
Agitation	19 (31.7)	Urine MDMA screen (+)	12/45
Hallucination	19 (31.7)	Urine ketamine screen (+)	19/45
Altered mental status (GCS <15)	15 (25.0)	Urine opioid screen (+)	2/38
Mydriasis	9 (15.0)	Urine benzodiazepine screen (+)	18/35
Tremor	8 (13.3)
Nausea/vomiting	8 (13.3)	Treatments
Short of breath	8 (13.3)	Gastric lavage	2 (3.3)
Chest pain	7 (11.7)	Activated charcoal	2 (3.3)
Sweating	7 (11.7)	Benzodiazepines	30 (50.0)
Combative behavior	6 (10.0)	Intubation	4 (6.7)
Concomitant trauma	6 (10.0)	Hemodialysis	1 (1.7)
Delirium	5 (8.3)
Seizure	4 (6.7)	Hospital flow
Visual felid defect	3 (5.0)	Discharge from ED	33 (55.0)
		Left AMA	11 (18.3)
Changes in vital signs		Admission (ward + ICU)	15 (25.0)
Tachycardia, HR >100/min	38 (63.3)	ICU admission	9 (15.0)
HR >120/min	18 (30.0)
Hypertension, SBP >140 mmHg	22 (36.7)	Severity and outcomes
SBP >160 mmHg	13 (21.7)	No symptoms (PSS:0)	1 (1.7)
Hyperthermia, BT >38°C	3 (5.0)	Minor (PSS:1)	34 (56.7)
BT >39°C	1 (1.7)	Moderate (PSS:2)	17 (28.3)
Tachypnea, RR > 20/min	10 (16.7)	Severe (PSS:3)	7 (11.7)
		Mortality (PSS:4)	1 (1.7)

GCS, Glasgow Coma Scale; HR, heart rate; SBP, systolic blood pressure; BT, body temperature; RR, respiratory rate; Cr, serum creatinine level; CK, creatine kinase, Na, serum sodium level; MDMA, 3,4-methylenedioxymethamphetamine; ED, emergency department; AMA, against medical advice; ICU, intensive care unit; PSS, Poisoning Severity Score.

Figure 2.

Case numbers over the years.

Most patients had mild to moderate toxicity and were discharged from the ED after symptom relief. Fifteen patients (25%) were admitted, of whom nine (15%) were admitted to an ICU. More than half were treated with benzodiazepines, and four were intubated. The only fatality was a 37-year-old male who developed agitation, seizure, and ventricular tachycardia following ingestion of toxic coffee packets and unknown sedatives. He was admitted to the ICU and eventually died from the poisoning. Confirmation tests (by mass-spectrometry-based analysis) were available in 10 patients (including the fatal case), and all these patients’ urine samples tested positive for at least one kind of synthetic cathinone. Detailed test results and analytical methods applied are shown in Table 2. Polysubstance exposure following toxic coffee packet ingestion was common; seven of these 10 patients were exposed to more than one kind of synthetic cathinone, and the most frequently detected illicit drug other than synthetic cathinones was ketamine.

Table 2.

Clinical presentations and confirmation test results in 10 patients. The admission urine samples of these patients were sent to a regional reference laboratory unit and tested qualitatively for commonly abused drugs using the standard mass spectrometry at that time.

Patient	Age/sex	Substances	Clinical presentations	ED flow, outcome	Urine drug screen (P/N)			Confirmation test results (urine)
Patient	Age/sex	Substances	Clinical presentations	ED flow, outcome	Am	MDMA	K	Cathinone derivatives	Other drugs	Tests used
1	37/M	Instant coffee packets, unknown sedatives	Agitation, seizure, palpitation, hypertension, developed ventricular tachycardia, eventually expired even after resuscitation	ICU, expired	N	N	N	N-Ethylpentylone	25B-NBOMe	LC-MSMS
2	26/M	Instant coffee packets	Agitation, hallucination, tachycardia, rhabdomyolysis and AKI	General ward, survived	P	P	N	Butylone, 4-CMC, dibutylone, N-ethylpentylone, mephedrone, methylone	—	LC-MSMS
3	19/M	Instant coffee packets	AMS, agitation, mydriasis, polyuria, hyponatremia (Na, 120 mEq/L)	Discharge, survived	N	N	N	4-CMC	—	LC-MSMS
4	35/M	Instant coffee packets, mixed prescription drugs	AMS, delirium, hallucination and hypertension	Discharge, survived	N	N	N	N-Ethylpentylone, mephedrone, methylone	—	LC-TOF, GCMS
5	31/M	Instant coffee packets	Visual field defect with spontaneous recovery	Discharge, survived	P	P	P	4-CEC, 4-MEAP, mephedrone	Ketamine	LC-TOF, GCMS
6	34/F	Instant coffee packets	Visual field defect with spontaneous recovery	Discharge, survived	P	P	P	Mephedrone, methcathinone	Ketamine	LC-TOF, GCMS
7	27/M	Instant coffee packets, ketamine	Agitation, hallucination, combative behavior and tachycardia	Discharge, survived	P	N	P	Mephedrone, methcathinone	Ketamine, norketamine	LC-MSMS
8	19/M	Instant coffee packets	Agitation, hallucination, tachycardia, chest pain, mydriasis, sweating, and blurred vision	Discharge, survived	P	N	N	4-Chloro-N,N-DMC, 4-chloroethcathinone, 4-chloromethcathinone, eutylone, mephedrone	Amphetamine, methamphetamine	LC-MSMS
9	18/M	Instant coffee packets	Hallucination, chest pain, short of breath, and tremor	Discharge, survived	N	N	N	Chloroethcathinone, eutylone, mehpedrone	—	LC-MSMS
10	27/M	Instant coffee packets, nitrous oxide	AMS, seizure, tachycardia, been intubated and admitted to ICU	ICU, survived	N	N	N	Mephedrone	—	LC-MSMS

M, male; F, female; AKI, acute kidney injury; AMS, altered mental status; Na, serum sodium level; ICU, intensive care unit; Am, amphetamine; MDMA, 3,4-methylenedioxymethamphetamine; K, ketamine; P, positive; N, negative; 4-CMC, 4-chloromethcathinone; 4-CEC, 4-chloroethcathinone; 4-MEAP, 4-methyl-α-ethylaminopentiophenone; 4-chloro-N,N-DMC, 4-chloro-N,N-dimethylcathinone; LC-MSMS, liquid chromatography–tandem mass spectrometry; GCMS, gas chromatography–tandem mass spectrometry; LC-TOF, liquid chromatography–time of flight mass spectrometry.

To identify the potential risk factors associated with ICU admission after toxic coffee packet ingestion, we further compared demographic and clinical characteristics between patients who needed ICU care and those who did not (Table 3). Patients who needed ICU care had a worse initial GCS score, higher respiratory rate, higher rate of experiencing seizures, higher white blood cell count, lower bicarbonate level, and higher intubation rate and were more likely to have significant acidemia (pH < 7.25). To evaluate the predictive role of each parameter, we used a receiver operating characteristic (ROC) curve to find the best cutoff value that predicted ICU admission. A GCS score ≤13 was found to have the best predictive value (sensitivity, 77.8%; specificity, 88.2%), and the area under the curve was 0.86 (95% CI 0.69–1.0). When all variables with a p-value less than 0.1 in univariate analysis were fitted into a multivariate logistic regression model, only GCS score ≤13 (OR 29.4, 95% CI 2.9–297.3) and the presence of seizure (OR 32.3, 95% CI 1.3–784.1) were significantly associated with ICU admission.

Table 3.

Comparison of patients who were and were not admitted to the ICU.

Characteristic	Non-ICU admission	ICU admission	p Value
No. of patients	51	9
Age (years, mean ± SD)	29.4 ± 9.6	25.8 ± 6.6	0.283
Male gender	39 (76.5)	8 (88.9)	0.369
Hyperthermia (BT > 38 C)	1 (2.0)	2 (22.2)	0.056
Intentional	43 (84.3)	9 (100.0)	0.443
Toxic coffee packet use only	37 (72.6)	6 (66.7)	0.782
HR > 120 beats/min	13 (25.5)	5 (55.6)	0.081
SBP > 140 mmHg	18 (35.3)	4 (44.4)	0.283
RR > 20	6 (11.8)	4 (44.4)	0.0343
AMS
GCS < 15	8 (15.7)	7 (77.8)	0.0005
GCS < 13	6 (11.8)	7 (77.8)	0.0001
Seizure	1 (2.0)	3 (33.3)	0.009
Laboratory data
Leukocytosis	19/45 (42.2)	8/9 (88.9)	0.0122
Cr elevation	6/44 (13.6)	4/9 (44.4)	0.053
CK > 10,000 U/L	2/11 (18.2)	1/8 (12.5)	0.830
Na < 135 mEq/L	5/43 (11.6)	0/9 (0)	1
Blood pH < 7.25	1/37 (2.7)	3/9 (33.3)	0.0198
Bicarbonate < 20 mEq/L	4/37 (10.8)	4/9 (44.4)	0.0359
Lactate elevation	1/4	4/6	n/a
Intubation	0 (0)	4 (44.4)	0.0003
Death	0 (0)	1 (11.1)	0.150

Discussion

In this study, we report clinical characteristics, presentations, and outcomes of ED patients who reported ingestion of toxic coffee packets, a new pattern of synthetic cathinone use in Taiwan. Patients ingesting toxic coffee packets usually presented with sympathomimetic symptoms, which were mainly neurologic and cardiovascular symptoms and combative behavior. Mortality was rare in our series, but it did occur. Based on the confirmation test results in 10 patients, we considered that patients who reported ingesting these products were very likely to be exposed to synthetic cathinones. Multiple psychoactive substances exposure after toxic coffee packet ingestion was common.

Individuals who ingested toxic coffee packets tended to be young and predominantly male. This finding is similar to some reports of synthetic cathinone poisoning from other countries.^11,22–24 According to data from the Taiwan Food and Drug Administration (TFDA), the most predominant illicit drug used by people older than 40 years old in Taiwan is heroin, followed by amphetamine/methamphetamine. Illicit ketamine and other NPS are more popular in young people aged less than 30 years.¹⁵ A single-center study from Taiwan showed that lab-confirmed NPS users (mean age, 27.0 ± 9.9 years) were significantly younger than traditional drug (heroin or amphetamine/methamphetamine) users (37.0 ± 9.1 years).¹⁹ A possible explanation is that ketamine and toxic coffee packets cost less (10–20 USD for each packet) and are more affordable for young people and students.¹³ Another potential reason is that ketamine and some popular synthetic cathinones (e.g., mephedrone, methylone, chloromethcathinone, methyl-α-ethylaminopentiophenone, 4-chloroethcathinone, and ethylone) are classified as Schedule III drugs in Taiwan. Illicit narcotics and psychoactive agents are divided into four categories (Schedule I to Schedule IV) in Taiwan based on their addictive potential, illicit use liability, and social harm liability.^25,26 Unlike Schedule I or II drugs, illicit use of these Schedule III drugs does not involve criminal responsibility and is punished only with an administrative fine.²⁶ First-time users, usually young people, might feel less guilty and be more willing to use these drugs and share them with friends.

According to the confirmation test results in some of our patients, multiple substance exposure is common among toxic coffee packet users. Previous case series from Taiwan demonstrated the same finding.^17–19 A recent study from Taiwan further reported that polysubstance exposure was more common in NPS users than in traditional drug users.¹⁹ Polysubstance use was also a common phenomenon in “bath salt” users in the United States and Europe.^27–29 Since the majority of our patients reported ingesting only toxic coffee packets, our findings indirectly imply that patients who ingested this product in fact simultaneously ingested various psychoactive substances. Both consumers and sellers, most likely unknowingly, are confronted with the risk of criminalization and potential harm. Some evidence showed that concurrent exposure to other stimulants with synthetic cathinones may enhance toxicity.^30–32 The only fatality in our series (case no. 1 in Table 2) was exposed to a mixture of NPS including N-ethylpentylone and 25B-NBOMe (a phenethylamine derivative) following ingestion of toxic coffee packets. This new pattern of polysubstance exposure caused by toxic coffee packets has brought new threats to public health in Taiwan. Moreover, this phenomenon may have occurred in some of the other Southeast Asian countries despite not being formally reported in the literature.

Synthetic cathinones activate central serotonergic and dopaminergic systems. Patients who ingest toxic coffee packets usually present with sympathomimetic symptoms, which are similar to those produced by methamphetamine and MDMA toxicity.^24,33 Interestingly, hyperthermia was relatively uncommon in our series; three patients (5%) had a BT > 38°C, and only one patient had significant hyperthermia with a BT > 39°C. In a series involving 81 patients with laboratory-confirmed cathinone use in southern Germany, hyperthermia (>38.5°C) was noted only in 4% of patients.²⁹ Some other reports have shown similar findings.^10,22 In an animal study, brain and body hyperthermic effects of methylone and MDPV in rats were modest in magnitude (<2°C) even at relatively high drug doses that exceeded the range of “typical” human recreational consumption.³⁴ A larger clinical study should be conducted to confirm this observation.

Significant hyponatremia occurred in one of our patients (case no. 3 in Table 2). This 19-year-old male ingested a few toxic coffee packets and several liters of water and developed polyuria and hypo osmolar hyponatremia with a serum sodium level of 120 meq/L. He responded well to normal saline infusion and was discharged on the following day. 4-Chloromethcathinone was the only psychoactive drug detected in a further confirmation test (Table 2). Hyponatremia is a rare presentation in synthetic cathinone poisoning.^35,36 It may be caused by excessive sweating with electrolyte loss and increased free water consumption during cathinone use (presumably the main reason for hyponatremia in our case). Additionally, some synthetic cathinones possess an MDMA-like effect, which can result in hyponatremia by inducing secretion of antidiuretic hormone mediated via serotonin.³⁵

Peripheral visual field defects occurred in three of our patients following ingestion of toxic coffee packets. These patients received serial examinations, including brain imaging and ophthalmoscopy, and no abnormal findings were revealed except subtle macular edema in one patient. Their visual symptoms all subsided within a few days. Confirmation tests were available in two patients, which showed they had been exposed to cathinone mixtures and ketamine. In a large series of 236 patients exposed to bath salts and legal highs, blurred vision was found in seven patients (3%).²² In a Scottish survey involving 205 students who used mephedrone, 21% reported the adverse effect of blurred vision.³ However, there was no further description in either study. Decreased visual acuity or transient loss of vision and retinal hemorrhage have been reported in amphetamine and cocaine abuse.^37,38 Most of these ocular effects are thought to be due to the sympathomimetic effects of vasoconstriction or vasospasm.³⁷ It is reasonable to assume that synthetic cathinones may have a similar effect although the exact mechanism has not been well studied.

In response to the rapid emergence of NPS with molecular structures that were not covered by legislation, several countries have created new mechanisms of control, with accelerated ways to restrict the free sale and distribution of these substances.² The prevalence of an illicit substance usually decreases once it has been well scheduled.³⁹ In Taiwan, TFDA and the Ministry of Justice have controlled the majority of commonly abused synthetic cathinones since the early 2010s. However, the prevalence of synthetic cathinones continued to rise after scheduling.¹⁴ There are a few possible explanations. First, most of the popular synthetic cathinones are classified as Category III substances in Taiwan. Although the production, transportation, or distribution of these substances is criminal, possession of small amounts or use of them is not a criminal offense.²⁶ Second, legislative mechanisms tend to be rigid in Taiwan. A drug should be proved to possess addictive potential, abuse liability, and social harm liability before it can be controlled.¹⁴ However, it is usually difficult to prove promptly whether a new psychoactive drug is addictive and, in turn, difficult to collect data on its abuse and social harm liability. A study showed that compared to the neighboring countries China, Japan, and South Korea, Taiwan controlled the fewest NPS.⁴⁰ Third, synthetic cathinone use is seldom identified and reported in healthcare facilities because of the unavailability of adequate laboratory capacity and unawareness of synthetic cathinone poisoning patterns.¹⁵ Reporting by healthcare facilities could provide important toxic surveillance information in NPS abuse; however, this has not been successful in Taiwan. Moreover, the public does not have sufficient knowledge of toxic coffee packets and synthetic cathinone toxicity. To mitigate the harmful influence of toxic coffee packets, education for both the public and healthcare providers should be emphasized, and laboratory capacity should be enhanced.

This study has several limitations. First, this is a retrospective study including a small number of ED patients. The rate of each presentation and mortality may not be precisely evaluated. Second, confirmation tests were not available in most of our cases, and a unified testing method could not be achieved because this was a retrospective study covering a time span of 5 years. Moreover, a newly introduced NPS would not be correctly identified because the testing was focused on the known illicit drugs or NPS in Taiwan. Third, the inclusion basically relied on exposure history, which may not be correct in some cases. However, based on the high positive rate of illicit drug detection in patients’ urine samples in some of our cases, we consider that most of the inclusions were reliable.

Conclusions

ED patients who report ingesting “toxic coffee packets” are very likely to have been exposed to synthetic cathinones and present with sympathomimetic symptoms. Exposure to multiple psychoactive substances is common following ingestion. Although most patients recovered rapidly after supportive treatment, severe complications such as rhabdomyolysis, AKI, and life-threatening cardiac arrhythmia can occur. A GCS score ≤ 13 and the presence of seizure are associated with the need for ICU care. To provide appropriate diagnosis and management, physicians should be aware of this new pattern of synthetic cathinone poisoning.

Footnotes

Acknowledgments

The authors would like to thank the following reference laboratory units for conducting the confirmation tests: (1) Clinical Toxicology & Occupational Medicine Division, Internal Medicine Department in Taipei Veteran General Hospital and (2) Forensic & Clinical Toxicology Center in College of Medicine, National Taiwan University Hospital.

Authors’ contribution

H-H Chou and C-H Hsieh are both the first authors. The first two authors contributed equally to this article.

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by Chang-Gung Memorial Hospital Research Grants (CMRPG3H0921 and CMRPG3H0922).

ORCID iDs

C-H Chaou

C-K Chen

T-H Yen

References

United Nations Office on Drugs and Crime (UNODC). World Drug Report 2019. Available at: https://wdr.unodc.org/wdr2019/ (accessed 12 November 2019).

Weinstein

Rosca

Fattore

, et al. Synthetic cathinone and cannabinoid designer drugs pose a major risk for public health. Front Psychiatry. 2017; 8: 156.

Dargan

Albert

Wood

. Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. QJM 2010; 103: 875–879.

Palamar

. “Bath salt” use among a nationally representative sample of high school seniors in the United States. Am J Addict 2015; 24: 488–491.

Schifano

Napoletano

Arillotta

, et al. The clinical challenges of synthetic cathinones. Br J Clin Pharmacol 2020; 86: 410–419.

German

Fleckenstein

Hanson

. Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life Sci 2014; 97: 2–8.

Kelly

. Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. Drug Test Anal 2011; 3: 439–453.

Glennon

Young

Martin

, et al. Methcathione (“cat”): an enantiomeric potency comparison. Pharmacol Biochem Behav 1995; 50: 601–606.

Wood

Davies

Greene

, et al. Case series of individuals with analytically confirmed acute mephedrone toxicity. Clin Toxicol (Phila) 2010; 48: 924–927.

10.

Beck

Franzen

Backberg

, et al. Intoxications involving MDPV in Sweden during 2010-2014: results from the STRIDA project. Clin Toxicol (Phila) 2015; 53: 865–873.

11.

Kamijo

Takai

Fujita

, et al. A multicenter retrospective survey of poisoning after consumption of products containing novel psychoactive substances from 2013 to 2014 in Japan. Am J Drug Alcohol Abuse 2016; 42: 513–519.

12.

Schifano

Orsolini

Duccio Papanti

, et al. Novel psychoactive substances of interest for psychiatry. World Psychiatry 2015; 14: 15–26.

13.

Lee

Hsu

Tsay

. The trend of drug abuse in Taiwan during the years 1999 to 2011. J Food Drug Anal 2013; 21: 390–396.

14.

Feng

. New psychoactive substances in Taiwan: challenges and strategies. Curr Opin Psychiatry 2020; 33: 306–311.

15.

Taiwan Food and Drug Administration. 2018 Annual report of the statistical data of drug abuse cases and laboratory testing. Available at: https://www.fda.gov.tw/tc/site.aspx?sid=10051 (accessed 16 May 2020).

16.

Ministry of Education, Ministry of Justice, Ministry of Health and Welfare, Ministry of Foreign Affairs, Republic of China (Taiwan). Anti-drug report. Available at: https://antidrug.moj.gov.tw/lp-95-2-xCat-en.html (2015, accessed 16 May 2020).

17.

Weng

Chen

, et al. Analytically confirmed 4-methyl-N-ethylnorpentedrone (4-MEAP), a synthetic cathinone, in cases presenting to an emergency department. Clin Toxicol (Phila) 2020; 58: 65–66.

18.

Chang

Tracy

Huang

, et al. Psychiatric profiles and clinical manifestations of cathinone users: case series of analytically confirmed cathinone use in Taiwan. J Addict Addictv Disord 2019; 6: 023.

19.

Weng

Chen

, et al. Characteristics of analytically confirmed illicit substance-using patients in the emergency department. J Formos Med Assoc 2020; 119: 1827–1834.

20.

Liechti

. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling. Swiss Med Wkly 2015; 145: w14043.

21.

Persson

Sjoberg

Haines

Pronczuk de Garbino

Poisoning severity score. Grading of acute poisoning. J Toxicol Clin Toxicol 1998; 36: 205–213.

22.

Spiller

Ryan

Weston

Jansen

. Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States. Clin Toxicol (Phila) 2011; 49: 499–505.

23.

Regan

Mitchelson

Macdonald

. Mephedrone toxicity in a Scottish emergency department. Emerg Med J 2011; 28: 1055–1058.

24.

Warrick

Hill

Hekman

, et al. A 9-state analysis of designer stimulant, “bath salt,” hospital visits reported to poison control centers. Ann Emerg Med 2013; 62: 244–251.

25.

Ministry of Justice, Republic of China (Taiwan). Narcotics Hazard Prevention Act. Available at: https://law.moj.gov.tw/ENG/LawClass/LawAll.aspx?pcode=C0000008 (accessed 04 November 2020).

26.

Feng

Wada

Chung

, et al. Comparison of legislative management for new psychoactive substances control among Taiwan, South Korea, and Japan. Kaohsiung J Med Sci 2020; 36: 135–142.

27.

Centers for Disease C and Prevention. Emergency department visits after use of a drug sold as “bath salts” – Michigan, November 13, 2010-March 31, 2011. MMWR Morb Mortal Wkly Rep 2011; 60: 624–627.

28.

Beck

Backberg

Signell

Helander

Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats. Clin Toxicol (Phila) 2018; 56: 256–263.

29.

Romanek

Stenzel

Schmoll

, et al. Synthetic cathinones in Southern Germany – characteristics of users, substance-patterns, co-ingestions, and complications. Clin Toxicol (Phila) 2017; 55: 573–578.

30.

Schifano

Corkery

Ghodse

. Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, “meow meow”) in the United Kingdom. J Clin Psychopharmacol 2012; 32: 710–714.

31.

Angoa-Perez

Kane

Briggs

, et al. Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA. J Neurochem 2013; 125: 102–110.

32.

Busardo

Kyriakou

Napoletano

, et al. Mephedrone related fatalities: a review. Eur Rev Med Pharmacol Sci 2015; 19: 3777–3790.

33.

Mas-Morey

Visser

Winkelmolen

, et al. Clinical toxicology and management of intoxications with synthetic cathinones (“bath salts”). J Pharm Pract 2013; 26: 353–357.

34.

Kiyatkin

Kim

Wakabayashi

, et al. Effects of social interaction and warm ambient temperature on brain hyperthermia induced by the designer drugs methylone and MDPV. Neuropsychopharmacology 2015; 40: 436–445.

35.

Sammler

Foley

Lauder

, et al.

A harmless high?

Lancet 2010; 376: 742.

36.

Boulanger-Gobeil

St-Onge

Laliberte

, et al. Seizures and hyponatremia related to ethcathinone and methylone poisoning. J Med Toxicol 2012; 8: 59–61.

37.

Wallace

Brown

Benson

, et al. Sudden retinal manifestations of intranasal cocaine and methamphetamine abuse. Am J Ophthalmol 1992; 114: 158–160.

38.

Zeiter

Corder

Madion

McHenry

. Sudden retinal manifestations of intranasal cocaine and methamphetamine abuse. Am J Ophthalmol 1992; 114: 780–781.

39.

Riley

Nelson

, et al. Abuse potential and toxicity of the synthetic cathinones (i.e., “Bath salts”). Neurosci Biobehav Rev 2020; 110: 150–173.

40.

Feng

Chang

, et al. Comparison of illegal drug use pattern in Taiwan and Korea from 2006 to 2014. Subst Abuse Treat Prev Policy 2016; 11: 34.